What is the drug of choice for bacterial pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug of Choice for Bacterial Pharyngitis

Penicillin or amoxicillin is the recommended drug of choice for bacterial pharyngitis due to Group A Streptococcus (GAS) based on their proven efficacy, safety, narrow spectrum of activity, and low cost. 1

First-Line Treatment Options

For patients without penicillin allergy:

  • Oral Penicillin V:

    • Adults: 250 mg 2-3 times daily for 10 days
    • Children: Weight-based dosing for 10 days
  • Oral Amoxicillin (alternative with equivalent efficacy):

    • 50 mg/kg once daily (maximum 1000 mg) for 10 days 1, 2
    • Advantage: Once-daily dosing may improve adherence
    • Particularly useful for young children due to better taste acceptance
  • Intramuscular Benzathine Penicillin G (single dose):

    • Preferred for patients unlikely to complete a full oral course
    • <60 lb (27 kg): 600,000 units IM
    • 60 lb (27 kg): 1,200,000 units IM 2

Alternative Treatments for Penicillin-Allergic Patients

For patients with penicillin allergy:

  1. First-generation cephalosporins (if not anaphylactically sensitive):

    • Cephalexin: 20 mg/kg twice daily (max 500 mg per dose) for 10 days
    • Cefadroxil: 30 mg/kg once daily (max 1 g) for 10 days 1, 2
  2. Clindamycin: 7 mg/kg per dose three times daily for 10 days 1, 2

    • Excellent coverage against GAS with minimal resistance reported in the US
  3. Clarithromycin: 7.5 mg/kg twice daily (max 250 mg per dose) for 10 days 2

  4. Azithromycin: 12 mg/kg once daily (max 500 mg) for 5 days 1, 2, 3

    • Note: FDA-approved for shorter course (5 days)
    • Caution: Macrolide resistance has been reported in up to 5% of GAS in the US

Treatment Considerations

Efficacy and Resistance

  • Penicillin-resistant GAS has never been documented 1
  • The 10-day duration for most antibiotics is necessary to achieve maximal pharyngeal eradication of GAS 1
  • While some newer antibiotics (cefdinir, cefpodoxime, azithromycin) are FDA-approved for shorter courses, the IDSA does not endorse these shorter regimens due to broader spectrum and higher cost 1

Medications to Avoid

  • Tetracyclines: High prevalence of resistant strains
  • Sulfonamides and trimethoprim-sulfamethoxazole: Do not eradicate GAS
  • Older fluoroquinolones (e.g., ciprofloxacin): Limited activity against GAS
  • Newer fluoroquinolones: Unnecessarily broad spectrum and expensive 1

Adjunctive Therapy

  • Acetaminophen or ibuprofen for pain and fever control
  • Avoid aspirin in children (risk of Reye syndrome) 2

Follow-up Recommendations

  • Patients are considered non-contagious after 24 hours of antibiotic therapy 2
  • Clinical response typically occurs within 24-48 hours of starting treatment 1, 2
  • Follow-up throat cultures or rapid antigen detection tests are not routinely recommended 1
  • Complete the full antibiotic course even if symptoms resolve quickly 2

Important Caveats

  • GAS pharyngitis is usually self-limited, but treatment reduces symptom duration and prevents complications like acute rheumatic fever 1
  • If symptoms persist after 5 days of appropriate treatment, consider:
    • Non-compliance with prescribed regimen
    • Penicillin treatment failure
    • New GAS infection
    • Viral pharyngitis in a GAS carrier 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Group A Streptococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.